Human leucocyte antigen class I and killer immunoglobulin‐like receptor expression patterns in T‐cell large granular lymphocyte leukaemia
Open Access
- 1 February 2005
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 128 (4) , 490-492
- https://doi.org/10.1111/j.1365-2141.2004.05341.x
Abstract
T-cell large granular lymphocyte leukaemia (T-LGLL) is often associated with suppression of haematopoiesis through unknown mechanisms. Killer immunoglobulin-like receptors (KIRs) binding human-leucocyte antigen (HLA)-I in an allele-specific manner are frequently expressed by T-LGLL cells. HLA-I genotyping was performed in seven T-LGLL cases in which the neoplastic cells were known to express a single KIR isoform (CD158a, CD158b or CD158e). Five cases showed absence of the cognate HLA-I antigen for the expressed KIR isoform, resulting in KIR/HLA-I ‘mismatch’. Cytopenias occurred in all five ‘mismatch’ patients but not in two patients with ‘match’, suggesting that KIR/HLA-I mismatch may contribute to the suppression of haematopoiesis.Keywords
This publication has 12 references indexed in Scilit:
- Demonstration of aberrant T‐cell and natural killer‐cell antigen expression in all cases of granular lymphocytic leukaemiaBritish Journal of Haematology, 2003
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme BBlood, 2002
- Chronic neutropenia mediated by Fas ligandBlood, 2000
- Pure Red-Cell Aplasia Associated with Clonal Expansion of Granular Lymphocytes Expressing Killer-Cell Inhibitory ReceptorsNew England Journal of Medicine, 1999
- Molecular genetics and lymphoproliferative disordersJournal of Clinical Laboratory Analysis, 1996
- The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.The Journal of Experimental Medicine, 1995
- HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.Proceedings of the National Academy of Sciences, 1993
- Large Granular Lymphocyte LeukemiaMedicine, 1987